ATP2A2 and heart failure: However, while these results provide compelling evidence that Atp2a2 heterozygosity does not impair cardiac function in middle-aged humans, they do not rule out the possibility that SERCA2 haploinsufficiency can increase susceptibility to disease progression and heart failure.